Trial intelligence / Profile preview

Split-dosing versus non-split dosing of ergocalciferol in chronic kidney disease

TCTR20200820007Phase 3Completed

Start
Mar 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of vitamin d in Vitamin D deficiency (VDD), sponsored by None. Started Mar 2019; status: completed.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on TCTR20200820007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200820007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call